Clinical Trial: I.V Papavrine for Labor Induction in Term PROM

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517796) titled 'I.V Papavrine for Labor Induction in Term PROM' on Jan. 07.

Brief Summary: This prospective randomized controlled trial aims to evaluate whether intravenous administration of papaverine 12 hours after term PROM reduces the interval from membrane rupture to delivery and improves maternal and neonatal outcomes. Researchers will compare drug papaverine to a placebo

Study Start Date: Oct. 22, 2025

Study Type: INTERVENTIONAL

Condition: Premature Rupture of Membranes

Intervention: DRUG: Papaverine arm

given 12 houres after rupture of membranes

OTHER: Placebo

I.V seline

Recruitment Status: RECRUITING

Sponsor: Western Galilee Hos...